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Introduction 
Toxoplasmosis is an opportunistic infection in 
patients with HIV infection and is a life threatening 
condition in particular in stage IV of AIDS. Most 
cases of toxoplasmosis involve the central nervous 
system and muscles including the heart [1-4].  
Studies from Nairobi by Brindle et al in 1991 showed 
that 54% of HIV infected patients had toxoplasma 
specific 1gG antibodies and 22% of the HIV positive 
group had 1gG levels indicative of active 
toxoplasmosis.  This is in contrast to 1% of the HIV 
negative group [5]. Toxoplasmosis presenting as 
hepatomegaly as the major clinical finding is rare. 
 
Case report 
JM, a 40 year old male secondary school teacher 
from Machakos District, Eastern Province, Kenya 
was diagnosed to have HIV infection in December 
2002.  He had presented with fever, painful flanks, 
occasional cough and oral thrush. Systemic 
examination was unremarkable.  He was put on 
clotrimazole mouth paint, multivitamin and 
diclofenac tablets.  Investigations done included full 
Haemogram-Hb-13.3g/dl, WBC – 5.3 x 109IL with 
22% lymphocytes and 78% granulocytes, HIV 
antibodies were positive and urinalysis was normal.  
He was counselled and advised on antiretroviral 
treatment. He did not come for follow-up until 
December 2003 when he presented with 2 months 
history of cough, loose stools, malaise, fatigue and 
left leg pitting oedema.  Investigations done; stool 
had no ova or cysts, full haemogram: HB-8.0g/dl, 
WBC-3.0 X 1109/IL 51% lymphocytes and 40% 
granulocytes, red blood cells were normocytic and 
normochromic and a platelet count of 108 x 109/IL. 
He was subsequently started on lamivudine 
150mgBD, stavudine 30mgBD and nevirapine 
200mg BD (EMTRI), haematinics and 
cotrimoxazole. 
      He was seen again in February 2004 with 2 days 
history of fever, chills, diarrhoea and inability to 
feed. Examination revealed a wasted young man with 
pallor, pedal oedema, Kaposi’s sarcoma like looking  
 
lesions on the left foot planter surface medial aspect, 
no lymphadenopathy but had herpetic lesions at 
angles of mouth.  Abdominal examination revealed 
enlarged liver with span of 20cm, non-tender, firm, 
smooth and had no bruit. There was no ascites or 
splenomegaly. Rest of examination was 
unremarkable. He was transfused two units of blood 
and liver biopsy done using Meghini’s technique. 
      The liver specimen was fixed in 10% formal 
saline and processed using paraffin wax processing 
techniques.  4µm thick sections were cut and stained 
using Haematoxylin and Eosin method.  Giemsa stain 
was used to demonstrate the tachyzoites of 
Toxoplasma.  Microscopy showed liver tissue with 
mildly distorted hepatic cords.  The hapatocytes were 
reactive and showed cytoplasmic inclusions bodies 
confirmed to be tachyzoites of Toxoplasma gondii by 
giemsa stain. 
       No Malignancy was seen. The iron stainable was 
adequate. No cirrhosis was seen. The patient was 
started on fansidar 4 tablets daily for 1 week then 
three tablets daily for another 6 weeks. The liver 
regressed and patient started feeding well again 
within one week of treatment. He was to continue 
with the rest of treatment as an outpatient. He was 
reviewed after completion of treatment and had 
recovered and the liver was not palpable.  The patient 
however, did not come back for further follow-up. 
 
Discussion 
Toxoplasmosis is a disease caused by the obligate 
intracellular coccidian protozoa Toxoplasma gondii.  
This single celled parasite has a worldwide 
distribution. It exists in three forms namely 
tachyzoite, cyst and oocyst. It infects herbivorous, 
omnivorous and carnivorous animals including birds 
and reptiles.  Tachyzotes invade all mammalian cells 
except the nonnucleated erythrocytes and are found 
in tissues during the acute phase of infection.  Cysts 
are formed within host cells and may contain 
thousands of organisms.  Cysts play a major role in 
disease transmission, as may be ingested by 
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carnivores. Once ingested, the cysts may release 
tachyzoites, which penetrate the intestinal wall into 
circulation to cause disease.  Tachyzoites may encyst 
in many organs where they may persist for a long 
time but skeletal and heart muscles and central 
nervous system are the most common sites of latent 
infection.  Oocysts are only formed in mucosal cells 
of feline intestines and are subsequently excreted in 
faeces.  The cat is the definitive host of Toxoplasma 
gondii.  Ingestion of oocyst also plays a major role in 
disease transmission. 
       Disease prevalence varies from place to place; it 
tends to increase with age. Eating raw or 
undercooked meat infects people, harbouring cysts, 
eating uncooked foods that have come in contact with 
infected meat and accidental ingestion of 
contaminated soil containing cat faeces. Less 
common modes of transmission include blood 
transfusion, organ transplant and transplacentally.  
There is otherwise no evidence that the disease can 
be transmitted directly from person to person.  Most 
cases of Toxoplasmosis in HIV infected patients 
appear to result from reactivation of dormant 
infection but new infections are still possible. 
       The most common clinical manifestation of 
Toxoplasmosis in HIV infected patients is 
encephalitis, which is usually caused by multiple 
focal brain lesions. Symptoms of Toxoplasmic 
encephalitis typically develop over course of days to 
weeks and often include focal neurological 
abnormalities such as weakness, speech disturbance, 
headache, confusion, lethargy and convulsions.  
Cranial nerve deficits, visual field defects movement 
and gait disorders, stroke, personality change and 
other neurologiacal and neuropsychiatric 
abnormalities may occur. Extracerebral 
Toxoplasmosis usually affects the eyes and lungs.  
Hepatic toxoplasmosis is rare.  
     Detection of Toxoplasma gondii infection is 
mainly by serology and histology. Serological testing 
detects toxoplasma specific immunoglobulin G (IgG) 
antibody. Toxoplasma specific immunoglobulin M 
(IgM) antibodies rise soon after acute infection but 
fall within weeks.  IgG titers rise within 2 months 
after infection and remains elevated for life. The 
presence of Toxoplasma IgM antibodies indicates 
that T. gondii infection is present while 1gm antibody 
suggests recent infection. Congenital Toxoplasmosis 
can be detected using Polymerase Chain Reaction 
(PCR) for DNA detection on amniotic fluid.  
Polymerase chain reaction can also be used on 
cerebral spinal fluid, brain tissue and whole blood.  
Confirmation of the presence of tachyzoites cysts is 
the definitive criteria for the diagnosis of 
Toxoplasmosis.  Isolation of tachyzoite from tissue is 
also possible but this takes up to 6 weeks. The 
standard treatment for Toxoplasmosis is a 
combination of Pyrimethamine and Sulfadiazine.  
Drug treatment should be for 6 weeks both in acute 
and reactivated infection. Hepatic Toxoplasmosis is a 
rare diagnosis in liver biopsies in Kenya. This case 
highlights the need for histopathological evaluation 
of the liver in cases of hepatomegally and HIV/AIDS. 
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